Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-GEF domain-containing family member 1A (RASGEF1A) is a protein encoded by the RASGEF1A gene in humans. It functions as a guanine nucleotide exchange factor (GEF) and is specific for Ras family GTPases such as RAP2A, KRAS, HRAS, and NRAS (at least in vitro). The protein facilitates Ras activation by promoting the exchange of GDP for GTP, regulating key cellular processes including cell migration and Ras-dependent signal transduction. It is predominantly found in the cytosol and may also be active at the plasma membrane. Dysregulation or mutations affecting Ras signaling are implicated in cancer and other diseases, making GEF proteins important for research into cancer mechanisms. However, RASGEF1A is not yet an established drug target, and further work will be needed to evaluate its utility for therapeutic intervention.
For theoretical or research-stage inhibitors: Inhibition of guanine nucleotide exchange factor activity, leading to decreased Ras activation and downstream signaling. For drugs targeting Ras family proteins indirectly: Blocking Ras-mediated MAPK pathway signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-GEF domain-containing family member 1A (RASGEF1A).